Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)
- 1 June 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (11) , 1308-1310
- https://doi.org/10.1016/s0002-9149(02)02334-2
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Hepatic Failure in a Patient Taking RosiglitazoneAnnals of Internal Medicine, 2000
- Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case ReportAnnals of Internal Medicine, 2000